The Stephenson Global Pancreatic Cancer Research Institute creates Global Scientific Awards to advance pancreatic cancer research

RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

HHS Secretary Robert F. Kennedy Jr. said he is considering a ban on government scientists publishing their work in top-tier medical journals, which he says are abed with pharmaceutical companies.

May 30, 2025

Vol.51 No.21

By Claire Marie Porter

Cancer Policy

MAHA report “Making our Children Healthy Again” focuses on ultraprocessed foods and is mum on tobacco

A recent report from the Make America Healthy Again Commission cites ultraprocessed foods, electromagnetic radiation, and herbicides as possible reasons for increased cancer incidence in children.

Abu-Rustum, Burt Nabors, Styler, Thompson receive 2025 NCCN awards

Nadeem R. Abu-RustumLouis Burt NaborsMichael J. StylerJames ThompsonErin HeslerNadeem R. Abu-Rustum, Louis Burt Nabors, Michael J. Styler, and James Thompson were recognized by the National Comprehensive Cancer Network as its 2025 awardees who “go above and beyond to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives.”

May 30, 2025

Vol.51 No.21

Clinical Roundup

Most Americans unaware of cancer risks associated with drinking alcohol

Alcohol is a leading preventable cause of cancer, but public awareness of the connection remains strikingly low in the U.S., with just 40% of American adults recognizing alcohol as a cancer risk, according to a new study from the University of Texas MD Anderson Cancer Center.

May 30, 2025

Vol.51 No.21

Clinical Roundup

Wildfire pollution may lower survival of lung cancer patients

Breathing in wildfire pollution may make it harder for people with lung cancer to survive, according to a new study from UC Davis Comprehensive Cancer Center researchers.

May 30, 2025

Vol.51 No.21

Clinical Roundup

New biomarker may guide best use of KRAS inhibitors in lung cancer

Researchers from the University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer, following treatment with the KRAS targeted therapy, sotorasib.

May 30, 2025

Vol.51 No.21

The Stephenson Global Pancreatic Cancer Research Institute creates Global Scientific Awards to advance pancreatic cancer research

YOU MAY BE INTERESTED IN

RFK Jr. floats the idea of barring government scientists from publishing in leading medical journals due to “corruption”

MAHA report “Making our Children Healthy Again” focuses on ultraprocessed foods and is mum on tobacco

Abu-Rustum, Burt Nabors, Styler, Thompson receive 2025 NCCN awards

Most Americans unaware of cancer risks associated with drinking alcohol

Wildfire pollution may lower survival of lung cancer patients

New biomarker may guide best use of KRAS inhibitors in lung cancer

Renew today!

Subscriber content

Never miss an issue!

Login